plerixafor has been researched along with Cirrhosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Cheng, Y; Gong, Y; Han, W; Liu, Z; Song, B; Zhang, R; Zhang, Z | 1 |
| Cao, J; Gao, Y; Ji, J; Jiao, Y; Pan, L; Xiao, Y; Yang, H; Yu, D; Zhang, Q; Zhang, S; Zhong, L; Zhu, W | 1 |
| Feng, Q; Feng, Y; Hou, FF; Liu, Y; Miao, J; Shen, W; Wu, Q; Zhou, L; Zhou, S | 1 |
| Fan, B; Fu, Y; Gao, F; Jiang, T; Li, T; Li, X; Li, Y; Liu, P; Qin, X; Sun, H; Wang, Q; Wang, Y; Zheng, Q; Zhou, X | 1 |
| Cui, ZL; Gu, C; Gu, JH; Lu, YW; Zou, XF | 1 |
| Falkenham, A; Issekutz, T; Lee, TD; Légaré, JF; Rosin, N; Sopel, M | 1 |
| Advani, A; Advani, SL; Chen, LH; Connelly, KA; Gibson, IW; Gilbert, RE; Kabir, MG; Kelly, DJ; Marsden, PA; Sood, MM; Thai, K; Yuen, DA | 1 |
| Anagnostopoulos, A; Athanasiou, E; Gounari, E; Siotou, E; Tsolaki, E; Yannaki, E; Yiangou, M; Zogas, N | 1 |
| Choi, U; Karihaloo, A; Lee, Y; Moeckel, G; Yuan, A | 1 |
| Byrne, M; Chu, PY; Horlock, D; Jandeleit-Dahm, K; Kaye, DM; Nelson, E; Walder, K; Williams, D; Zimmet, P | 1 |
| Guo, Y; Hu, Z; Liao, W; Mou, J; Pei, G; Sun, J; Wang, M; Wang, P; Wang, X; Xu, G; Yang, J; Yao, W; Yao, Y; Zeng, R; Zhao, Z; Zhu, F | 1 |
| Drucker, DJ; Fujishima, H; Fujita, H; Morii, T; Narita, T; Sato, T; Seino, Y; Shimizu, T; Takahashi, T; Takashima, S; Tsukiyama, K; Yamada, Y | 1 |
| Bachmann, S; Chander, P; Goligorsky, MS; Jasmin, JF; Lisanti, MP; Park, HC; Ratliff, B; Sharkovska, Y; Stoessel, A; Yamamoto, I; Yasuda, K | 1 |
13 other study(ies) available for plerixafor and Cirrhosis
| Article | Year |
|---|---|
Stromal cell-derived factor-1 exerts opposing roles through CXCR4 and CXCR7 in angiotensin II-induced adventitial remodeling.
Topics: Adventitia; Angiotensin II; Animals; Benzylamines; Cell Movement; Cell Proliferation; Chemokine CXCL12; Collagen; Cyclams; Disease Models, Animal; Fibroblasts; Fibrosis; Hypertension; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; Receptors, CXCR; Receptors, CXCR4; Signal Transduction; Wound Healing | 2022 |
The Involvement of SDF-1α/CXCR4 Axis in Radiation-Induced Acute Injury and Fibrosis of Skin.
Topics: Animals; Benzylamines; Chemokine CXCL12; Cyclams; Fibrosis; Gene Expression Regulation; Gene Knockout Techniques; Heterocyclic Compounds; Humans; Keratinocytes; MAP Kinase Signaling System; Mice; Phosphatidylinositol 3-Kinases; Radiation Injuries; Rats; Receptors, CXCR4; Skin; Smad2 Protein; Transforming Growth Factor beta | 2019 |
C-X-C motif chemokine receptor 4 aggravates renal fibrosis through activating JAK/STAT/GSK3β/β-catenin pathway.
Topics: Amino Acid Motifs; Animals; Benzylamines; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Chemokine CXCL12; Cyclams; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Gene Knockdown Techniques; Glycogen Synthase Kinase 3 beta; Humans; Janus Kinase 2; Kidney; Matrix Metalloproteinase 7; Mice; Pyrimidinones; Receptors, CXCR4; Renal Insufficiency, Chronic; STAT3 Transcription Factor; STAT6 Transcription Factor | 2020 |
CXCL12/CXCR4 axis as a key mediator in atrial fibrillation via bioinformatics analysis and functional identification.
Topics: Animals; Atrial Fibrillation; Benzylamines; Case-Control Studies; Chemokine CXCL12; Computational Biology; Cyclams; Databases, Genetic; Disease Models, Animal; Electrocardiography; Fibrosis; Gene Expression Profiling; Gene Ontology; Gene Regulatory Networks; Heart Atria; Humans; Inflammation; Macrophages; Mice, Inbred C57BL; Phosphorylation; Receptors, CXCR4; Signal Transduction; T-Lymphocytes; Vascular Remodeling | 2021 |
CXC Chemokine Receptor Type 4 Antagonism Ameliorated Allograft Fibrosis in Rat Kidney Transplant Model.
Topics: Allografts; Animals; Benzylamines; Chemokine CXCL12; Collagen Type IV; Cyclams; Disease Models, Animal; Down-Regulation; Fibrosis; Graft Survival; Heterocyclic Compounds; Kidney; Kidney Diseases; Kidney Transplantation; Male; Rats, Inbred F344; Rats, Inbred Lew; Receptors, CXCR4; Signal Transduction; Time Factors; Transforming Growth Factor beta1 | 2017 |
Early fibroblast progenitor cell migration to the AngII-exposed myocardium is not CXCL12 or CCL2 dependent as previously thought.
Topics: Angiotensin II; Animals; Benzylamines; Cell Movement; Cell Proliferation; Chemokine CCL2; Chemokine CXCL12; Cyclams; Fibroblasts; Fibrosis; Heterocyclic Compounds; Male; Mice; Mice, Inbred C57BL; Myocardium; Receptors, CXCR4; Stem Cells; Up-Regulation; Vasoconstrictor Agents | 2013 |
SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzylamines; Biopsy; Capillaries; Cell Line; Chemokine CXCL12; Cyclams; Fibrosis; Glomerulosclerosis, Focal Segmental; Heterocyclic Compounds; Humans; Immunohistochemistry; Kidney; Kidney Function Tests; Nephrectomy; Nitric Oxide Synthase Type III; Perindopril; Phosphorylation; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; Receptors, CXCR4; Renal Insufficiency, Chronic; RNA, Messenger; Serine; Signal Transduction | 2014 |
Hematopoietic stem cells and liver regeneration: differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury.
Topics: Animals; Benzylamines; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury, Chronic; Cyclams; Fibrosis; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Immunohistochemistry; Liver; Liver Regeneration; Mice; Time Factors | 2014 |
Chemokine receptor Cxcr4 contributes to kidney fibrosis via multiple effectors.
Topics: Animals; Benzylamines; Bone Morphogenetic Protein 7; Cyclams; Fibrosis; Heterocyclic Compounds; Kidney; Macrophage Activation; Male; Mice, Inbred C57BL; Nephrosclerosis; Receptors, CXCR4; Transforming Growth Factor beta1; Up-Regulation; Ureteral Obstruction | 2015 |
CXCR4 Antagonism Attenuates the Development of Diabetic Cardiac Fibrosis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzylamines; Biphenyl Compounds; Bone Marrow Transplantation; Chemokine CXCL12; Cyclams; Diabetic Cardiomyopathies; Disease Models, Animal; Fibrosis; Heart Ventricles; Hemodynamics; Heterocyclic Compounds; Humans; Mice; Mice, Transgenic; Myofibroblasts; Receptors, CXCR4; Tetrazoles | 2015 |
Continuous AMD3100 Treatment Worsens Renal Fibrosis through Regulation of Bone Marrow Derived Pro-Angiogenic Cells Homing and T-Cell-Related Inflammation.
Topics: Animals; Benzylamines; Bone Marrow; CD3 Complex; Cell Proliferation; Chemotaxis; Collagen Type IV; Cyclams; Cytokines; Fibrosis; Heterocyclic Compounds; Hypoxia; Inflammation; Kidney; Kidney Tubules; Male; Mice, Inbred C57BL; Neovascularization, Physiologic; Receptor, Platelet-Derived Growth Factor beta; T-Lymphocytes; Ureteral Obstruction | 2016 |
Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy.
Topics: Albuminuria; Animals; Benzylamines; Chemokine CXCL12; Cyclams; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Female; Fibrosis; Glomerular Filtration Rate; Glucagon-Like Peptide-1 Receptor; Heterocyclic Compounds; Humans; Hypoglycemic Agents; Kidney; Linagliptin; Liraglutide; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Receptors, CXCR4; Up-Regulation | 2016 |
Postobstructive regeneration of kidney is derailed when surge in renal stem cells during course of unilateral ureteral obstruction is halted.
Topics: Animals; Benzylamines; Caveolin 1; Cell Division; Chemokine CXCL12; Cyclams; Disease Progression; Enzyme Inhibitors; Fibrosis; Hematopoietic Stem Cells; Heterocyclic Compounds; Kidney; Kidney Cortex; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred Strains; Nitric Oxide Synthase; omega-N-Methylarginine; Receptors, CXCR4; Recovery of Function; Regeneration; Stem Cells; Ureteral Obstruction | 2010 |